nodes	percent_of_prediction	percent_of_DWPC	metapath
Verapamil—ABCC2—esophageal cancer	0.255	0.731	CbGaD
Verapamil—ABCB1—esophageal cancer	0.0937	0.269	CbGaD
Verapamil—ABCC10—Methotrexate—esophageal cancer	0.0593	0.134	CbGbCtD
Verapamil—ABCC3—Cisplatin—esophageal cancer	0.0574	0.13	CbGbCtD
Verapamil—ABCC3—Methotrexate—esophageal cancer	0.0373	0.0843	CbGbCtD
Verapamil—ABCC2—Carboplatin—esophageal cancer	0.0305	0.0691	CbGbCtD
Verapamil—ABCC4—Methotrexate—esophageal cancer	0.0285	0.0644	CbGbCtD
Verapamil—ABCG2—Carboplatin—esophageal cancer	0.0276	0.0625	CbGbCtD
Verapamil—ABCC2—Cisplatin—esophageal cancer	0.0261	0.059	CbGbCtD
Verapamil—ABCG2—Cisplatin—esophageal cancer	0.0236	0.0534	CbGbCtD
Verapamil—ABCC1—Methotrexate—esophageal cancer	0.0229	0.0518	CbGbCtD
Verapamil—SLCO1A2—Methotrexate—esophageal cancer	0.0204	0.0462	CbGbCtD
Verapamil—SLCO1B1—Methotrexate—esophageal cancer	0.0193	0.0436	CbGbCtD
Verapamil—CYP2C9—Capecitabine—esophageal cancer	0.0174	0.0394	CbGbCtD
Verapamil—ABCC2—Methotrexate—esophageal cancer	0.0169	0.0383	CbGbCtD
Verapamil—CYP2B6—Cisplatin—esophageal cancer	0.0166	0.0375	CbGbCtD
Verapamil—ABCG2—Methotrexate—esophageal cancer	0.0153	0.0347	CbGbCtD
Verapamil—CYP2C9—Cisplatin—esophageal cancer	0.00877	0.0198	CbGbCtD
Verapamil—ABCB1—Cisplatin—esophageal cancer	0.00851	0.0192	CbGbCtD
Verapamil—ABCB1—Methotrexate—esophageal cancer	0.00552	0.0125	CbGbCtD
Verapamil—SLC22A4—larynx—esophageal cancer	0.00349	0.0827	CbGeAlD
Verapamil—CACNB3—bronchus—esophageal cancer	0.00135	0.0318	CbGeAlD
Verapamil—Hyperkeratosis—Capecitabine—esophageal cancer	0.00124	0.0389	CcSEcCtD
Verapamil—CACNB3—trachea—esophageal cancer	0.00121	0.0286	CbGeAlD
Verapamil—CACNB4—lung—esophageal cancer	0.00113	0.0268	CbGeAlD
Verapamil—CACNA1G—digestive system—esophageal cancer	0.00113	0.0267	CbGeAlD
Verapamil—CYP2C18—bronchus—esophageal cancer	0.00107	0.0254	CbGeAlD
Verapamil—CACNA1B—lung—esophageal cancer	0.00106	0.025	CbGeAlD
Verapamil—CACNB3—digestive system—esophageal cancer	0.00104	0.0246	CbGeAlD
Verapamil—CACNA1I—lymph node—esophageal cancer	0.000942	0.0223	CbGeAlD
Verapamil—CACNA1H—smooth muscle tissue—esophageal cancer	0.000936	0.0222	CbGeAlD
Verapamil—SLC22A4—neck—esophageal cancer	0.000926	0.0219	CbGeAlD
Verapamil—CACNB3—lung—esophageal cancer	0.000868	0.0205	CbGeAlD
Verapamil—CYP2C18—digestive system—esophageal cancer	0.000828	0.0196	CbGeAlD
Verapamil—Ileus paralytic—Capecitabine—esophageal cancer	0.000818	0.0257	CcSEcCtD
Verapamil—ABCB11—digestive system—esophageal cancer	0.000805	0.0191	CbGeAlD
Verapamil—CACNA1B—lymph node—esophageal cancer	0.000722	0.0171	CbGeAlD
Verapamil—Joint swelling—Capecitabine—esophageal cancer	0.000721	0.0226	CcSEcCtD
Verapamil—CACNA1C—smooth muscle tissue—esophageal cancer	0.000713	0.0169	CbGeAlD
Verapamil—CACNB2—digestive system—esophageal cancer	0.000698	0.0165	CbGeAlD
Verapamil—ABCC10—bronchus—esophageal cancer	0.00066	0.0156	CbGeAlD
Verapamil—Hepatotoxicity—Cisplatin—esophageal cancer	0.000622	0.0195	CcSEcCtD
Verapamil—SLC22A4—bronchus—esophageal cancer	0.00062	0.0147	CbGeAlD
Verapamil—CACNB1—lymph node—esophageal cancer	0.000619	0.0146	CbGeAlD
Verapamil—CACNB3—lymph node—esophageal cancer	0.000594	0.014	CbGeAlD
Verapamil—ABCC10—trachea—esophageal cancer	0.000593	0.014	CbGeAlD
Verapamil—CACNB2—lung—esophageal cancer	0.000583	0.0138	CbGeAlD
Verapamil—Infection—Carboplatin—esophageal cancer	0.00058	0.0182	CcSEcCtD
Verapamil—CACNA1C—digestive system—esophageal cancer	0.000563	0.0133	CbGeAlD
Verapamil—SLC22A4—trachea—esophageal cancer	0.000557	0.0132	CbGeAlD
Verapamil—ABCC4—bronchus—esophageal cancer	0.000548	0.013	CbGeAlD
Verapamil—SCN5A—digestive system—esophageal cancer	0.000546	0.0129	CbGeAlD
Verapamil—SLCO1B1—digestive system—esophageal cancer	0.00054	0.0128	CbGeAlD
Verapamil—ABCC3—digestive system—esophageal cancer	0.000512	0.0121	CbGeAlD
Verapamil—ABCC10—digestive system—esophageal cancer	0.00051	0.0121	CbGeAlD
Verapamil—CACNA1D—lung—esophageal cancer	0.00051	0.0121	CbGeAlD
Verapamil—Ileus—Capecitabine—esophageal cancer	0.0005	0.0157	CcSEcCtD
Verapamil—Pain—Carboplatin—esophageal cancer	0.000499	0.0157	CcSEcCtD
Verapamil—SLC22A4—digestive system—esophageal cancer	0.000479	0.0113	CbGeAlD
Verapamil—CACNA1C—lung—esophageal cancer	0.00047	0.0111	CbGeAlD
Verapamil—ABCC1—bronchus—esophageal cancer	0.000467	0.0111	CbGeAlD
Verapamil—Hepatotoxicity—Capecitabine—esophageal cancer	0.000458	0.0144	CcSEcCtD
Verapamil—SLCO1A2—digestive system—esophageal cancer	0.000439	0.0104	CbGeAlD
Verapamil—Petechiae—Capecitabine—esophageal cancer	0.00043	0.0135	CcSEcCtD
Verapamil—ABCC3—lung—esophageal cancer	0.000428	0.0101	CbGeAlD
Verapamil—ABCC10—lung—esophageal cancer	0.000426	0.0101	CbGeAlD
Verapamil—SLC6A4—digestive system—esophageal cancer	0.000425	0.0101	CbGeAlD
Verapamil—ABCC4—digestive system—esophageal cancer	0.000423	0.01	CbGeAlD
Verapamil—CACNA1H—lymph node—esophageal cancer	0.000422	0.01	CbGeAlD
Verapamil—ABCC1—trachea—esophageal cancer	0.000419	0.00992	CbGeAlD
Verapamil—SLC22A5—bronchus—esophageal cancer	0.000411	0.00972	CbGeAlD
Verapamil—ABCC2—digestive system—esophageal cancer	0.000409	0.00969	CbGeAlD
Verapamil—Contusion—Capecitabine—esophageal cancer	0.000405	0.0127	CcSEcCtD
Verapamil—SLC22A4—lung—esophageal cancer	0.0004	0.00948	CbGeAlD
Verapamil—CACNB2—lymph node—esophageal cancer	0.000399	0.00944	CbGeAlD
Verapamil—Paralysis—Methotrexate—esophageal cancer	0.000379	0.0119	CcSEcCtD
Verapamil—KCNJ11—lymph node—esophageal cancer	0.000378	0.00896	CbGeAlD
Verapamil—SLC22A5—trachea—esophageal cancer	0.000369	0.00873	CbGeAlD
Verapamil—SLCO1A2—lung—esophageal cancer	0.000367	0.00869	CbGeAlD
Verapamil—CYP2B6—bronchus—esophageal cancer	0.000357	0.00844	CbGeAlD
Verapamil—Cerebrovascular accident—Cisplatin—esophageal cancer	0.000355	0.0112	CcSEcCtD
Verapamil—SLC6A4—lung—esophageal cancer	0.000355	0.00839	CbGeAlD
Verapamil—ABCC4—lung—esophageal cancer	0.000353	0.00836	CbGeAlD
Verapamil—CYP2C19—digestive system—esophageal cancer	0.000352	0.00833	CbGeAlD
Verapamil—CACNA1D—lymph node—esophageal cancer	0.000349	0.00825	CbGeAlD
Verapamil—Hepatotoxicity—Methotrexate—esophageal cancer	0.000341	0.0107	CcSEcCtD
Verapamil—CACNA1C—lymph node—esophageal cancer	0.000322	0.00762	CbGeAlD
Verapamil—Petechiae—Methotrexate—esophageal cancer	0.00032	0.01	CcSEcCtD
Verapamil—Ecchymosis—Capecitabine—esophageal cancer	0.00032	0.01	CcSEcCtD
Verapamil—Orthostatic hypotension—Cisplatin—esophageal cancer	0.000318	0.00999	CcSEcCtD
Verapamil—SLC22A5—digestive system—esophageal cancer	0.000317	0.00751	CbGeAlD
Verapamil—Cramp muscle—Cisplatin—esophageal cancer	0.000314	0.00985	CcSEcCtD
Verapamil—ABCC1—lung—esophageal cancer	0.000301	0.00713	CbGeAlD
Verapamil—Sleep disorder—Capecitabine—esophageal cancer	0.000297	0.00931	CcSEcCtD
Verapamil—Sweating increased—Cisplatin—esophageal cancer	0.000293	0.00921	CcSEcCtD
Verapamil—ABCC3—lymph node—esophageal cancer	0.000293	0.00693	CbGeAlD
Verapamil—ABCC10—lymph node—esophageal cancer	0.000291	0.00689	CbGeAlD
Verapamil—Abdominal discomfort—Cisplatin—esophageal cancer	0.000289	0.00906	CcSEcCtD
Verapamil—CYP1A2—digestive system—esophageal cancer	0.000287	0.0068	CbGeAlD
Verapamil—Vascular purpura—Capecitabine—esophageal cancer	0.000287	0.00901	CcSEcCtD
Verapamil—Hepatic enzyme increased—Methotrexate—esophageal cancer	0.000278	0.00874	CcSEcCtD
Verapamil—CYP3A5—digestive system—esophageal cancer	0.000277	0.00656	CbGeAlD
Verapamil—CYP2B6—digestive system—esophageal cancer	0.000275	0.00652	CbGeAlD
Verapamil—SLC22A4—lymph node—esophageal cancer	0.000274	0.00648	CbGeAlD
Verapamil—CYP2C9—digestive system—esophageal cancer	0.000273	0.00646	CbGeAlD
Verapamil—Vasculitis—Methotrexate—esophageal cancer	0.00027	0.00847	CcSEcCtD
Verapamil—Respiratory failure—Methotrexate—esophageal cancer	0.000268	0.00842	CcSEcCtD
Verapamil—Purpura—Capecitabine—esophageal cancer	0.000266	0.00836	CcSEcCtD
Verapamil—SLC22A5—lung—esophageal cancer	0.000265	0.00627	CbGeAlD
Verapamil—Acute coronary syndrome—Cisplatin—esophageal cancer	0.000265	0.00831	CcSEcCtD
Verapamil—Myocardial infarction—Cisplatin—esophageal cancer	0.000263	0.00826	CcSEcCtD
Verapamil—Cardiac failure—Capecitabine—esophageal cancer	0.000263	0.00826	CcSEcCtD
Verapamil—Cerebrovascular accident—Capecitabine—esophageal cancer	0.000262	0.00823	CcSEcCtD
Verapamil—Lethargy—Capecitabine—esophageal cancer	0.000262	0.00823	CcSEcCtD
Verapamil—Diplopia—Capecitabine—esophageal cancer	0.000257	0.00806	CcSEcCtD
Verapamil—ABCG2—lung—esophageal cancer	0.000249	0.0059	CbGeAlD
Verapamil—Bradycardia—Cisplatin—esophageal cancer	0.000245	0.0077	CcSEcCtD
Verapamil—Cardiac arrest—Capecitabine—esophageal cancer	0.000244	0.00767	CcSEcCtD
Verapamil—ABCC4—lymph node—esophageal cancer	0.000242	0.00572	CbGeAlD
Verapamil—CYP1A2—lung—esophageal cancer	0.00024	0.00568	CbGeAlD
Verapamil—Ecchymosis—Methotrexate—esophageal cancer	0.000238	0.00747	CcSEcCtD
Verapamil—Gynaecomastia—Methotrexate—esophageal cancer	0.000236	0.0074	CcSEcCtD
Verapamil—Orthostatic hypotension—Capecitabine—esophageal cancer	0.000235	0.00736	CcSEcCtD
Verapamil—Pulmonary oedema—Methotrexate—esophageal cancer	0.000234	0.00736	CcSEcCtD
Verapamil—ABCC2—lymph node—esophageal cancer	0.000234	0.00554	CbGeAlD
Verapamil—Visual impairment—Cisplatin—esophageal cancer	0.000232	0.00729	CcSEcCtD
Verapamil—CYP3A5—lung—esophageal cancer	0.000231	0.00548	CbGeAlD
Verapamil—CYP2B6—lung—esophageal cancer	0.00023	0.00545	CbGeAlD
Verapamil—Muscular weakness—Capecitabine—esophageal cancer	0.000226	0.00711	CcSEcCtD
Verapamil—Tinnitus—Cisplatin—esophageal cancer	0.000225	0.00705	CcSEcCtD
Verapamil—Flushing—Cisplatin—esophageal cancer	0.000224	0.00702	CcSEcCtD
Verapamil—Influenza—Capecitabine—esophageal cancer	0.000222	0.00697	CcSEcCtD
Verapamil—Bronchospasm—Capecitabine—esophageal cancer	0.000218	0.00685	CcSEcCtD
Verapamil—Sweating increased—Capecitabine—esophageal cancer	0.000216	0.00679	CcSEcCtD
Verapamil—Angina pectoris—Capecitabine—esophageal cancer	0.000216	0.00679	CcSEcCtD
Verapamil—Alopecia—Cisplatin—esophageal cancer	0.000213	0.00669	CcSEcCtD
Verapamil—Abdominal discomfort—Capecitabine—esophageal cancer	0.000213	0.00668	CcSEcCtD
Verapamil—CYP3A4—digestive system—esophageal cancer	0.000208	0.00492	CbGeAlD
Verapamil—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000206	0.00648	CcSEcCtD
Verapamil—ABCC1—lymph node—esophageal cancer	0.000206	0.00488	CbGeAlD
Verapamil—CYP2D6—digestive system—esophageal cancer	0.000205	0.00485	CbGeAlD
Verapamil—Muscle spasms—Cisplatin—esophageal cancer	0.000202	0.00633	CcSEcCtD
Verapamil—Vision blurred—Cisplatin—esophageal cancer	0.000198	0.00621	CcSEcCtD
Verapamil—Tremor—Cisplatin—esophageal cancer	0.000197	0.00617	CcSEcCtD
Verapamil—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000196	0.00616	CcSEcCtD
Verapamil—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000195	0.00612	CcSEcCtD
Verapamil—Lethargy—Methotrexate—esophageal cancer	0.000195	0.00612	CcSEcCtD
Verapamil—Cerebrovascular accident—Methotrexate—esophageal cancer	0.000195	0.00612	CcSEcCtD
Verapamil—Myocardial infarction—Capecitabine—esophageal cancer	0.000194	0.00609	CcSEcCtD
Verapamil—ABCB1—epithelium—esophageal cancer	0.000194	0.00458	CbGeAlD
Verapamil—Jaundice—Capecitabine—esophageal cancer	0.000193	0.00606	CcSEcCtD
Verapamil—KCNH2—lymph node—esophageal cancer	0.000192	0.00454	CbGeAlD
Verapamil—Convulsion—Cisplatin—esophageal cancer	0.000182	0.00571	CcSEcCtD
Verapamil—SLC22A5—lymph node—esophageal cancer	0.000181	0.00429	CbGeAlD
Verapamil—Bradycardia—Capecitabine—esophageal cancer	0.000181	0.00568	CcSEcCtD
Verapamil—Myalgia—Cisplatin—esophageal cancer	0.000179	0.00561	CcSEcCtD
Verapamil—Rhinitis—Capecitabine—esophageal cancer	0.000178	0.00559	CcSEcCtD
Verapamil—Hepatitis—Capecitabine—esophageal cancer	0.000178	0.00558	CcSEcCtD
Verapamil—Hypoaesthesia—Capecitabine—esophageal cancer	0.000177	0.00555	CcSEcCtD
Verapamil—Discomfort—Cisplatin—esophageal cancer	0.000176	0.00554	CcSEcCtD
Verapamil—Pharyngitis—Capecitabine—esophageal cancer	0.000176	0.00554	CcSEcCtD
Verapamil—Oedema peripheral—Capecitabine—esophageal cancer	0.000175	0.00549	CcSEcCtD
Verapamil—Anaphylactic shock—Cisplatin—esophageal cancer	0.000171	0.00537	CcSEcCtD
Verapamil—Oedema—Cisplatin—esophageal cancer	0.000171	0.00537	CcSEcCtD
Verapamil—Visual impairment—Capecitabine—esophageal cancer	0.000171	0.00537	CcSEcCtD
Verapamil—ABCB1—trachea—esophageal cancer	0.000171	0.00405	CbGeAlD
Verapamil—ABCG2—lymph node—esophageal cancer	0.000171	0.00404	CbGeAlD
Verapamil—Infection—Cisplatin—esophageal cancer	0.00017	0.00534	CcSEcCtD
Verapamil—Erythema multiforme—Capecitabine—esophageal cancer	0.000168	0.00527	CcSEcCtD
Verapamil—Tachycardia—Cisplatin—esophageal cancer	0.000167	0.00525	CcSEcCtD
Verapamil—Tinnitus—Capecitabine—esophageal cancer	0.000166	0.0052	CcSEcCtD
Verapamil—Hyperhidrosis—Cisplatin—esophageal cancer	0.000166	0.0052	CcSEcCtD
Verapamil—Flushing—Capecitabine—esophageal cancer	0.000165	0.00518	CcSEcCtD
Verapamil—Hypotension—Cisplatin—esophageal cancer	0.00016	0.00502	CcSEcCtD
Verapamil—Abdominal discomfort—Methotrexate—esophageal cancer	0.000158	0.00497	CcSEcCtD
Verapamil—Alopecia—Capecitabine—esophageal cancer	0.000157	0.00493	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000156	0.0049	CcSEcCtD
Verapamil—Paraesthesia—Cisplatin—esophageal cancer	0.000154	0.00483	CcSEcCtD
Verapamil—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000154	0.00482	CcSEcCtD
Verapamil—Dyspnoea—Cisplatin—esophageal cancer	0.000153	0.00479	CcSEcCtD
Verapamil—Erectile dysfunction—Methotrexate—esophageal cancer	0.000152	0.00478	CcSEcCtD
Verapamil—Muscle spasms—Capecitabine—esophageal cancer	0.000149	0.00467	CcSEcCtD
Verapamil—Drowsiness—Methotrexate—esophageal cancer	0.000147	0.00462	CcSEcCtD
Verapamil—ABCB1—digestive system—esophageal cancer	0.000147	0.00349	CbGeAlD
Verapamil—Pain—Cisplatin—esophageal cancer	0.000146	0.0046	CcSEcCtD
Verapamil—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000146	0.00458	CcSEcCtD
Verapamil—Vision blurred—Capecitabine—esophageal cancer	0.000146	0.00458	CcSEcCtD
Verapamil—Tremor—Capecitabine—esophageal cancer	0.000145	0.00455	CcSEcCtD
Verapamil—Sweating—Methotrexate—esophageal cancer	0.000141	0.00443	CcSEcCtD
Verapamil—Feeling abnormal—Cisplatin—esophageal cancer	0.000141	0.00443	CcSEcCtD
Verapamil—Vertigo—Capecitabine—esophageal cancer	0.000139	0.00436	CcSEcCtD
Verapamil—Syncope—Capecitabine—esophageal cancer	0.000139	0.00435	CcSEcCtD
Verapamil—Palpitations—Capecitabine—esophageal cancer	0.000137	0.00429	CcSEcCtD
Verapamil—Loss of consciousness—Capecitabine—esophageal cancer	0.000136	0.00427	CcSEcCtD
Verapamil—Hypertension—Capecitabine—esophageal cancer	0.000134	0.00419	CcSEcCtD
Verapamil—Hepatitis—Methotrexate—esophageal cancer	0.000132	0.00415	CcSEcCtD
Verapamil—Arthralgia—Capecitabine—esophageal cancer	0.000132	0.00413	CcSEcCtD
Verapamil—Chest pain—Capecitabine—esophageal cancer	0.000132	0.00413	CcSEcCtD
Verapamil—Myalgia—Capecitabine—esophageal cancer	0.000132	0.00413	CcSEcCtD
Verapamil—Pharyngitis—Methotrexate—esophageal cancer	0.000131	0.00412	CcSEcCtD
Verapamil—Discomfort—Capecitabine—esophageal cancer	0.00013	0.00408	CcSEcCtD
Verapamil—Dry mouth—Capecitabine—esophageal cancer	0.000129	0.00404	CcSEcCtD
Verapamil—Visual impairment—Methotrexate—esophageal cancer	0.000127	0.004	CcSEcCtD
Verapamil—Confusional state—Capecitabine—esophageal cancer	0.000127	0.004	CcSEcCtD
Verapamil—Oedema—Capecitabine—esophageal cancer	0.000126	0.00396	CcSEcCtD
Verapamil—Hypersensitivity—Cisplatin—esophageal cancer	0.000126	0.00396	CcSEcCtD
Verapamil—Infection—Capecitabine—esophageal cancer	0.000125	0.00394	CcSEcCtD
Verapamil—Erythema multiforme—Methotrexate—esophageal cancer	0.000125	0.00393	CcSEcCtD
Verapamil—Shock—Capecitabine—esophageal cancer	0.000124	0.0039	CcSEcCtD
Verapamil—Tinnitus—Methotrexate—esophageal cancer	0.000123	0.00387	CcSEcCtD
Verapamil—Tachycardia—Capecitabine—esophageal cancer	0.000123	0.00387	CcSEcCtD
Verapamil—ABCB1—lung—esophageal cancer	0.000123	0.00291	CbGeAlD
Verapamil—Asthenia—Cisplatin—esophageal cancer	0.000123	0.00386	CcSEcCtD
Verapamil—Hyperhidrosis—Capecitabine—esophageal cancer	0.000122	0.00383	CcSEcCtD
Verapamil—Hypotension—Capecitabine—esophageal cancer	0.000118	0.0037	CcSEcCtD
Verapamil—Diarrhoea—Cisplatin—esophageal cancer	0.000117	0.00368	CcSEcCtD
Verapamil—Alopecia—Methotrexate—esophageal cancer	0.000117	0.00367	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000115	0.00361	CcSEcCtD
Verapamil—Insomnia—Capecitabine—esophageal cancer	0.000114	0.00358	CcSEcCtD
Verapamil—Paraesthesia—Capecitabine—esophageal cancer	0.000113	0.00356	CcSEcCtD
Verapamil—Dyspnoea—Capecitabine—esophageal cancer	0.000113	0.00353	CcSEcCtD
Verapamil—Dyspepsia—Capecitabine—esophageal cancer	0.000111	0.00349	CcSEcCtD
Verapamil—Vomiting—Cisplatin—esophageal cancer	0.000109	0.00342	CcSEcCtD
Verapamil—Fatigue—Capecitabine—esophageal cancer	0.000109	0.00342	CcSEcCtD
Verapamil—Vision blurred—Methotrexate—esophageal cancer	0.000108	0.00341	CcSEcCtD
Verapamil—Rash—Cisplatin—esophageal cancer	0.000108	0.00339	CcSEcCtD
Verapamil—Constipation—Capecitabine—esophageal cancer	0.000108	0.00339	CcSEcCtD
Verapamil—Pain—Capecitabine—esophageal cancer	0.000108	0.00339	CcSEcCtD
Verapamil—Dermatitis—Cisplatin—esophageal cancer	0.000108	0.00339	CcSEcCtD
Verapamil—Feeling abnormal—Capecitabine—esophageal cancer	0.000104	0.00327	CcSEcCtD
Verapamil—Vertigo—Methotrexate—esophageal cancer	0.000103	0.00325	CcSEcCtD
Verapamil—Nausea—Cisplatin—esophageal cancer	0.000102	0.00319	CcSEcCtD
Verapamil—Urticaria—Capecitabine—esophageal cancer	0.0001	0.00315	CcSEcCtD
Verapamil—Convulsion—Methotrexate—esophageal cancer	9.97e-05	0.00313	CcSEcCtD
Verapamil—Arthralgia—Methotrexate—esophageal cancer	9.8e-05	0.00308	CcSEcCtD
Verapamil—Chest pain—Methotrexate—esophageal cancer	9.8e-05	0.00308	CcSEcCtD
Verapamil—Myalgia—Methotrexate—esophageal cancer	9.8e-05	0.00308	CcSEcCtD
Verapamil—Discomfort—Methotrexate—esophageal cancer	9.68e-05	0.00304	CcSEcCtD
Verapamil—Confusional state—Methotrexate—esophageal cancer	9.47e-05	0.00297	CcSEcCtD
Verapamil—Anaphylactic shock—Methotrexate—esophageal cancer	9.4e-05	0.00295	CcSEcCtD
Verapamil—Infection—Methotrexate—esophageal cancer	9.33e-05	0.00293	CcSEcCtD
Verapamil—Hypersensitivity—Capecitabine—esophageal cancer	9.3e-05	0.00292	CcSEcCtD
Verapamil—Hyperhidrosis—Methotrexate—esophageal cancer	9.08e-05	0.00285	CcSEcCtD
Verapamil—Asthenia—Capecitabine—esophageal cancer	9.06e-05	0.00284	CcSEcCtD
Verapamil—Pruritus—Capecitabine—esophageal cancer	8.93e-05	0.0028	CcSEcCtD
Verapamil—Hypotension—Methotrexate—esophageal cancer	8.78e-05	0.00276	CcSEcCtD
Verapamil—Diarrhoea—Capecitabine—esophageal cancer	8.64e-05	0.00271	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Methotrexate—esophageal cancer	8.56e-05	0.00269	CcSEcCtD
Verapamil—Insomnia—Methotrexate—esophageal cancer	8.5e-05	0.00267	CcSEcCtD
Verapamil—Paraesthesia—Methotrexate—esophageal cancer	8.44e-05	0.00265	CcSEcCtD
Verapamil—ABCB1—lymph node—esophageal cancer	8.41e-05	0.00199	CbGeAlD
Verapamil—Dyspnoea—Methotrexate—esophageal cancer	8.38e-05	0.00263	CcSEcCtD
Verapamil—Somnolence—Methotrexate—esophageal cancer	8.35e-05	0.00262	CcSEcCtD
Verapamil—Dizziness—Capecitabine—esophageal cancer	8.35e-05	0.00262	CcSEcCtD
Verapamil—Dyspepsia—Methotrexate—esophageal cancer	8.27e-05	0.0026	CcSEcCtD
Verapamil—Fatigue—Methotrexate—esophageal cancer	8.1e-05	0.00254	CcSEcCtD
Verapamil—Pain—Methotrexate—esophageal cancer	8.03e-05	0.00252	CcSEcCtD
Verapamil—Vomiting—Capecitabine—esophageal cancer	8.02e-05	0.00252	CcSEcCtD
Verapamil—Rash—Capecitabine—esophageal cancer	7.96e-05	0.0025	CcSEcCtD
Verapamil—Dermatitis—Capecitabine—esophageal cancer	7.95e-05	0.0025	CcSEcCtD
Verapamil—Headache—Capecitabine—esophageal cancer	7.91e-05	0.00248	CcSEcCtD
Verapamil—Feeling abnormal—Methotrexate—esophageal cancer	7.74e-05	0.00243	CcSEcCtD
Verapamil—Nausea—Capecitabine—esophageal cancer	7.5e-05	0.00235	CcSEcCtD
Verapamil—Urticaria—Methotrexate—esophageal cancer	7.46e-05	0.00234	CcSEcCtD
Verapamil—Hypersensitivity—Methotrexate—esophageal cancer	6.92e-05	0.00217	CcSEcCtD
Verapamil—Asthenia—Methotrexate—esophageal cancer	6.74e-05	0.00212	CcSEcCtD
Verapamil—Pruritus—Methotrexate—esophageal cancer	6.65e-05	0.00209	CcSEcCtD
Verapamil—Diarrhoea—Methotrexate—esophageal cancer	6.43e-05	0.00202	CcSEcCtD
Verapamil—Dizziness—Methotrexate—esophageal cancer	6.21e-05	0.00195	CcSEcCtD
Verapamil—Vomiting—Methotrexate—esophageal cancer	5.97e-05	0.00188	CcSEcCtD
Verapamil—Rash—Methotrexate—esophageal cancer	5.92e-05	0.00186	CcSEcCtD
Verapamil—Dermatitis—Methotrexate—esophageal cancer	5.92e-05	0.00186	CcSEcCtD
Verapamil—Headache—Methotrexate—esophageal cancer	5.89e-05	0.00185	CcSEcCtD
Verapamil—Nausea—Methotrexate—esophageal cancer	5.58e-05	0.00175	CcSEcCtD
Verapamil—CYP3A7—Metabolism—ABCB1—esophageal cancer	5.44e-06	4.01e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—ADH1B—esophageal cancer	5.39e-06	3.97e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—GAPDH—esophageal cancer	5.39e-06	3.97e-05	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	5.38e-06	3.96e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—CRABP1—esophageal cancer	5.34e-06	3.93e-05	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—CREBBP—esophageal cancer	5.32e-06	3.92e-05	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—NOS3—esophageal cancer	5.32e-06	3.92e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—HMOX1—esophageal cancer	5.28e-06	3.89e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—ALDOB—esophageal cancer	5.27e-06	3.88e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	5.24e-06	3.86e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—ALDOB—esophageal cancer	5.23e-06	3.85e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—GNG7—esophageal cancer	5.2e-06	3.83e-05	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	5.2e-06	3.83e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—GSTT1—esophageal cancer	5.19e-06	3.83e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—TYMP—esophageal cancer	5.15e-06	3.8e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—CYP2A6—esophageal cancer	5.13e-06	3.78e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	5.11e-06	3.77e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CA2—esophageal cancer	5.1e-06	3.76e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—GNG7—esophageal cancer	5.08e-06	3.74e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—GAPDH—esophageal cancer	5.07e-06	3.74e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—ABCB1—esophageal cancer	5.07e-06	3.73e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—GAPDH—esophageal cancer	5.03e-06	3.71e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—CRABP1—esophageal cancer	5.03e-06	3.71e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CYP26A1—esophageal cancer	5.01e-06	3.69e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—CRABP1—esophageal cancer	4.99e-06	3.67e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—CREBBP—esophageal cancer	4.98e-06	3.67e-05	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—NOS3—esophageal cancer	4.97e-06	3.66e-05	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—NOS3—esophageal cancer	4.9e-06	3.61e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—CYP1B1—esophageal cancer	4.89e-06	3.6e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—ALOX15—esophageal cancer	4.88e-06	3.6e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—ALDH2—esophageal cancer	4.87e-06	3.59e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—ENO1—esophageal cancer	4.87e-06	3.59e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PTGS1—esophageal cancer	4.87e-06	3.59e-05	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—PTGS2—esophageal cancer	4.86e-06	3.58e-05	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—EP300—esophageal cancer	4.86e-06	3.58e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PSME2—esophageal cancer	4.8e-06	3.53e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PSME1—esophageal cancer	4.8e-06	3.53e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—GNG7—esophageal cancer	4.78e-06	3.52e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—CYP1B1—esophageal cancer	4.78e-06	3.52e-05	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—NOS3—esophageal cancer	4.77e-06	3.51e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—ALDH2—esophageal cancer	4.76e-06	3.51e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—ADH7—esophageal cancer	4.74e-06	3.5e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PLCE1—esophageal cancer	4.74e-06	3.5e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—GNG7—esophageal cancer	4.74e-06	3.49e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.72e-06	3.48e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—GSTO1—esophageal cancer	4.66e-06	3.43e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—TPI1—esophageal cancer	4.66e-06	3.43e-05	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—EP300—esophageal cancer	4.64e-06	3.42e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—GSTT1—esophageal cancer	4.64e-06	3.42e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—CREBBP—esophageal cancer	4.63e-06	3.42e-05	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—EP300—esophageal cancer	4.6e-06	3.39e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—CYP19A1—esophageal cancer	4.6e-06	3.39e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—CYP2A6—esophageal cancer	4.58e-06	3.38e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	4.56e-06	3.36e-05	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—PTGS2—esophageal cancer	4.55e-06	3.35e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—GSTT1—esophageal cancer	4.52e-06	3.33e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—CYP19A1—esophageal cancer	4.49e-06	3.31e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.48e-06	3.3e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—ALDH2—esophageal cancer	4.48e-06	3.3e-05	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—PTGS2—esophageal cancer	4.48e-06	3.3e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—CYP2A6—esophageal cancer	4.47e-06	3.3e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—ALDOB—esophageal cancer	4.47e-06	3.29e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—NOS3—esophageal cancer	4.46e-06	3.29e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—ALDH2—esophageal cancer	4.44e-06	3.27e-05	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—PTGS2—esophageal cancer	4.36e-06	3.21e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—ENO1—esophageal cancer	4.34e-06	3.2e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PTGS1—esophageal cancer	4.34e-06	3.2e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—GAPDH—esophageal cancer	4.3e-06	3.17e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PSME1—esophageal cancer	4.28e-06	3.15e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PSME2—esophageal cancer	4.28e-06	3.15e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—GSTT1—esophageal cancer	4.26e-06	3.14e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CRABP1—esophageal cancer	4.26e-06	3.14e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—ENO1—esophageal cancer	4.24e-06	3.12e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PTGS1—esophageal cancer	4.24e-06	3.12e-05	CbGpPWpGaD
Verapamil—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	4.24e-06	3.12e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—GSTT1—esophageal cancer	4.23e-06	3.11e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—CYP2A6—esophageal cancer	4.21e-06	3.11e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—HMOX1—esophageal cancer	4.19e-06	3.09e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	4.19e-06	3.09e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—CYP2A6—esophageal cancer	4.18e-06	3.08e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PSME2—esophageal cancer	4.18e-06	3.08e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PSME1—esophageal cancer	4.18e-06	3.08e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—CREBBP—esophageal cancer	4.17e-06	3.07e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—ERBB2—esophageal cancer	4.17e-06	3.07e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	4.16e-06	3.07e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—ADH1B—esophageal cancer	4.16e-06	3.07e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—NOS3—esophageal cancer	4.15e-06	3.06e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—CYP1B1—esophageal cancer	4.14e-06	3.05e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—HMOX1—esophageal cancer	4.1e-06	3.02e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—PTGS2—esophageal cancer	4.08e-06	3e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—GNG7—esophageal cancer	4.05e-06	2.99e-05	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—EP300—esophageal cancer	4.05e-06	2.98e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—ABCB1—esophageal cancer	4.03e-06	2.97e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—ENO1—esophageal cancer	4e-06	2.94e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PTGS1—esophageal cancer	4e-06	2.94e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—TYMP—esophageal cancer	3.98e-06	2.93e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—CREBBP—esophageal cancer	3.96e-06	2.92e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PTGS1—esophageal cancer	3.96e-06	2.92e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—ENO1—esophageal cancer	3.96e-06	2.92e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PSME1—esophageal cancer	3.94e-06	2.9e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PSME2—esophageal cancer	3.94e-06	2.9e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—ABCB1—esophageal cancer	3.93e-06	2.9e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PSME1—esophageal cancer	3.9e-06	2.88e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PSME2—esophageal cancer	3.9e-06	2.88e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—CYP19A1—esophageal cancer	3.89e-06	2.87e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CYP26A1—esophageal cancer	3.87e-06	2.85e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—ALDH2—esophageal cancer	3.8e-06	2.8e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—PTGS2—esophageal cancer	3.8e-06	2.8e-05	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—EP300—esophageal cancer	3.78e-06	2.79e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—ALOX15—esophageal cancer	3.77e-06	2.78e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.74e-06	2.75e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—NOS3—esophageal cancer	3.73e-06	2.75e-05	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—EP300—esophageal cancer	3.73e-06	2.75e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—CYP1B1—esophageal cancer	3.69e-06	2.72e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—CREBBP—esophageal cancer	3.67e-06	2.7e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—CREBBP—esophageal cancer	3.64e-06	2.68e-05	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—EP300—esophageal cancer	3.63e-06	2.67e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—GSTT1—esophageal cancer	3.61e-06	2.66e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—CYP1B1—esophageal cancer	3.61e-06	2.66e-05	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—PIK3CA—esophageal cancer	3.6e-06	2.65e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—GSTO1—esophageal cancer	3.6e-06	2.65e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—TPI1—esophageal cancer	3.6e-06	2.65e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CYP2A6—esophageal cancer	3.57e-06	2.63e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—CDKN1A—esophageal cancer	3.56e-06	2.63e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	3.56e-06	2.62e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—HMOX1—esophageal cancer	3.55e-06	2.62e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—NOS3—esophageal cancer	3.55e-06	2.61e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.48e-06	2.57e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—CYP19A1—esophageal cancer	3.47e-06	2.56e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—ALDOB—esophageal cancer	3.45e-06	2.54e-05	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—PIK3CA—esophageal cancer	3.43e-06	2.53e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—PTGS2—esophageal cancer	3.42e-06	2.52e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.41e-06	2.51e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—ABCB1—esophageal cancer	3.41e-06	2.51e-05	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—PIK3CA—esophageal cancer	3.41e-06	2.51e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—CYP1B1—esophageal cancer	3.4e-06	2.5e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—EP300—esophageal cancer	3.39e-06	2.5e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—CYP19A1—esophageal cancer	3.39e-06	2.5e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—CREBBP—esophageal cancer	3.39e-06	2.49e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—ENO1—esophageal cancer	3.38e-06	2.49e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PTGS1—esophageal cancer	3.38e-06	2.49e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—CYP1B1—esophageal cancer	3.37e-06	2.48e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PSME1—esophageal cancer	3.34e-06	2.46e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PSME2—esophageal cancer	3.34e-06	2.46e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—GAPDH—esophageal cancer	3.32e-06	2.44e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CRABP1—esophageal cancer	3.29e-06	2.42e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—NOS3—esophageal cancer	3.29e-06	2.42e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—NOS3—esophageal cancer	3.26e-06	2.4e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—PTGS2—esophageal cancer	3.25e-06	2.39e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—CYP19A1—esophageal cancer	3.19e-06	2.35e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—HMOX1—esophageal cancer	3.17e-06	2.33e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—CYP19A1—esophageal cancer	3.17e-06	2.33e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—EP300—esophageal cancer	3.16e-06	2.33e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—GNG7—esophageal cancer	3.13e-06	2.3e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.11e-06	2.29e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—HMOX1—esophageal cancer	3.09e-06	2.28e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—ABCB1—esophageal cancer	3.04e-06	2.24e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—NOS3—esophageal cancer	3.03e-06	2.23e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PTGS2—esophageal cancer	3.01e-06	2.21e-05	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—PIK3CA—esophageal cancer	2.99e-06	2.21e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PTGS2—esophageal cancer	2.98e-06	2.19e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—MYC—esophageal cancer	2.96e-06	2.18e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—ALDH2—esophageal cancer	2.93e-06	2.16e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—HMOX1—esophageal cancer	2.91e-06	2.15e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.91e-06	2.15e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—EGFR—esophageal cancer	2.89e-06	2.13e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—HMOX1—esophageal cancer	2.89e-06	2.13e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CYP1B1—esophageal cancer	2.88e-06	2.12e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—EP300—esophageal cancer	2.84e-06	2.09e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.83e-06	2.09e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—ABCB1—esophageal cancer	2.8e-06	2.06e-05	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—PIK3CA—esophageal cancer	2.8e-06	2.06e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—GSTT1—esophageal cancer	2.79e-06	2.05e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—ABCB1—esophageal cancer	2.77e-06	2.04e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PTGS2—esophageal cancer	2.77e-06	2.04e-05	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—PIK3CA—esophageal cancer	2.76e-06	2.03e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CYP2A6—esophageal cancer	2.76e-06	2.03e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CYP19A1—esophageal cancer	2.71e-06	1.99e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—EP300—esophageal cancer	2.7e-06	1.99e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—CREBBP—esophageal cancer	2.69e-06	1.98e-05	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—PIK3CA—esophageal cancer	2.68e-06	1.98e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—CREBBP—esophageal cancer	2.63e-06	1.94e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—ENO1—esophageal cancer	2.61e-06	1.92e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PTGS1—esophageal cancer	2.61e-06	1.92e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.58e-06	1.9e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PSME1—esophageal cancer	2.57e-06	1.9e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PSME2—esophageal cancer	2.57e-06	1.9e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—PIK3CA—esophageal cancer	2.51e-06	1.85e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—EP300—esophageal cancer	2.5e-06	1.84e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—EP300—esophageal cancer	2.48e-06	1.83e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—HMOX1—esophageal cancer	2.47e-06	1.82e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.42e-06	1.78e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—NOS3—esophageal cancer	2.41e-06	1.77e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—ABCB1—esophageal cancer	2.37e-06	1.75e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—NOS3—esophageal cancer	2.35e-06	1.73e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—PIK3CA—esophageal cancer	2.34e-06	1.72e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—EP300—esophageal cancer	2.31e-06	1.7e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.3e-06	1.69e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—CREBBP—esophageal cancer	2.28e-06	1.68e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CYP1B1—esophageal cancer	2.22e-06	1.64e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PTGS2—esophageal cancer	2.2e-06	1.62e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PTGS2—esophageal cancer	2.15e-06	1.59e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—PIK3CA—esophageal cancer	2.1e-06	1.55e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.1e-06	1.55e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CYP19A1—esophageal cancer	2.09e-06	1.54e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—NOS3—esophageal cancer	2.04e-06	1.5e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—CREBBP—esophageal cancer	2.03e-06	1.5e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—PIK3CA—esophageal cancer	2e-06	1.47e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—CREBBP—esophageal cancer	1.98e-06	1.46e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—HMOX1—esophageal cancer	1.91e-06	1.4e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—CREBBP—esophageal cancer	1.87e-06	1.38e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PTGS2—esophageal cancer	1.86e-06	1.37e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—CREBBP—esophageal cancer	1.85e-06	1.37e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PIK3CA—esophageal cancer	1.85e-06	1.36e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PIK3CA—esophageal cancer	1.83e-06	1.35e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—EP300—esophageal cancer	1.83e-06	1.35e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—ABCB1—esophageal cancer	1.83e-06	1.35e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—NOS3—esophageal cancer	1.82e-06	1.34e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.79e-06	1.32e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—EP300—esophageal cancer	1.79e-06	1.32e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—NOS3—esophageal cancer	1.78e-06	1.31e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PIK3CA—esophageal cancer	1.71e-06	1.26e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—NOS3—esophageal cancer	1.67e-06	1.23e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PTGS2—esophageal cancer	1.66e-06	1.23e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—NOS3—esophageal cancer	1.66e-06	1.22e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PTGS2—esophageal cancer	1.62e-06	1.2e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CREBBP—esophageal cancer	1.58e-06	1.17e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—EP300—esophageal cancer	1.55e-06	1.14e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PTGS2—esophageal cancer	1.53e-06	1.13e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PTGS2—esophageal cancer	1.52e-06	1.12e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—NOS3—esophageal cancer	1.42e-06	1.04e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—EP300—esophageal cancer	1.38e-06	1.02e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PIK3CA—esophageal cancer	1.36e-06	9.99e-06	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—EP300—esophageal cancer	1.35e-06	9.96e-06	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PIK3CA—esophageal cancer	1.32e-06	9.76e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PTGS2—esophageal cancer	1.3e-06	9.56e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—EP300—esophageal cancer	1.27e-06	9.38e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—EP300—esophageal cancer	1.26e-06	9.3e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CREBBP—esophageal cancer	1.22e-06	9.01e-06	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PIK3CA—esophageal cancer	1.15e-06	8.45e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—NOS3—esophageal cancer	1.09e-06	8.06e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—EP300—esophageal cancer	1.08e-06	7.95e-06	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PIK3CA—esophageal cancer	1.02e-06	7.55e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PTGS2—esophageal cancer	1e-06	7.38e-06	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PIK3CA—esophageal cancer	1e-06	7.37e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PIK3CA—esophageal cancer	9.42e-07	6.94e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PIK3CA—esophageal cancer	9.34e-07	6.88e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—EP300—esophageal cancer	8.33e-07	6.13e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PIK3CA—esophageal cancer	7.98e-07	5.88e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PIK3CA—esophageal cancer	6.16e-07	4.54e-06	CbGpPWpGaD
